ACADIA Pharmaceuticals Inc. leads Wednesday small-cap pre-market volume
Acorda Therapeutics Inc. (Nasdaq: ACOR) announced it is beginning the third clinical trial phase of its multiple sclerosis drug Fampridine-SR.
ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD) received a bullish mention from MSNBC pundit Jim Cramer Tuesday night.
Taleo Corp. (Nasdaq: TLEO) announced an offering of about 3.1 million shares of common stock priced at $19.85 per share.
After Tuesday’s closing bell, Volterra Semiconductor Corp. (Nasdaq: VLTR) warned second quarter sales are going to be between $18.5 million and $19.5 million, which is lower than its previous guidance.
Neurochem Inc. (Nasdaq: NRMX) announced it obtained written consent from shareholders for the private placement of $80 million in notes.
The following are the most actively traded companies in Wednesday pre-market trading among those with market capitalizations under $500 million:
| Price at | % | ||||||
| 9:14 et | Change | Change | Volume | Year High | Year Low |
